We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Our knowledge, expertise & publications
Deals & Cases
7 September 2021
Novaremed, a privately held clinical-stage biopharmaceutical company, expands its pipeline of non-opioid treatment candidates for chronic pain indications through the acquisition of Metys Pharmaceuticals. The acquisition broadens Novaremed’s existing pipeline by adding both clinical and preclinical development projects based on an innovative approach for non-opioid chronic pain treatment.
VISCHER AG advises Novaremed with a team led by Matthias Staehelin with Vincent Reardon, Luzius Zumstein, Cédric Saladin (all Corporate) and Nadia Tarolli with Adrian Briner (both Tax).
Categories: Corporate and Commercial, Life Sciences, Pharma, Biotech, Mergers & Acquisitions, Startup Desk, Deals & Cases
Attorney at Law and Civil Law Notary
Attorney at Law
Attorney at Law, Swiss Certified Tax Expert (2008)
Mosanna Therapeutics AG, a Basel-based biotechnology company developing the advanced small molecule...
Novaremed AG, a privately held clinical-stage biopharmaceutical company and NeuroFront Therapeutics...
Eurocine Vaccines and Redbiotec have signed a research and partnership agreement for the development...
Opt-in for our regular updates, news, views, insights and more.